SeaStar Medical Holding Corporation (ICU) - Latest Market Data

Price & Market Data

Price: $3.90

Daily Change: -$0.06 / 1.54%

Daily Range: $3.72 - $4.25

Market Cap: $14,988,758

Daily Volume: 137,536

Performance Metrics

1 Week: -3.80%

1 Month: -8.06%

3 Months: 68.78%

6 Months: 27.96%

1 Year: -68.85%

YTD: 71.61%

About SeaStar Medical Holding Corporation (ICU)

A complete market overview for SeaStar Medical Holding Corporation (ICU). The stock is at 3.90, with a daily change of -$0.06 / 1.54%. Market cap: 14,988,758. Delve into its YTD and 3-month performance.

Company Details

Employees: 17

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Selected stocks

Orion Digital Corp. (ORIO)

Rail Vision Ltd. (RVSN)

Aurora Cannabis Inc. (ACB)

Decent Holding Inc. (DXST)

TRX Gold Corporation (TRX)